Concepedia

Publication | Open Access

Anti-DFS70/LEDGF Antibodies Are More Prevalent in Healthy Individuals Compared to Patients with Systemic Autoimmune Rheumatic Diseases

DOIFull Paper Access

152

Citations

25

References

2012

Year

Michael Mähler, Todd A. Parker, Carol Peebles, Luís Eduardo Coelho Andrade, Andreas Swart, YVETTE CARBONE, David Ferguson, Danilo Villalta, Nicola Bizzaro, John G. Hanly,
The Journal of Rheumatology

Abstract

"Monospecific" anti-DFS70/LEDGF antibodies may represent a biomarker for differentiating SARD from non-SARD individuals, but there is a need for a reliable assay to ensure reactivity to DFS70.

References

YearCitations

Page 1